$35.45
0.05[0.14%]
At close: Apr 17
$35.45
0[0.00%]
After Hours: 4:20PM EDT
Collegium Pharmaceutical
(NASDAQ:COLL)Latest News for Collegium Pharmaceutical Stock (NASDAQ:COLL)
Collegium Pharmaceutical Stock (NASDAQ: COLL)
Categories: All
Thursday, April 11, 2024
Monday, February 26, 2024
Friday, February 23, 2024
Thursday, February 22, 2024
- Collegium Reaffirms Its Full-year 2024 Guidance For Product Revenues, Net, Adjusted Operating Expenses And Adjusted EBITDABenzinga Newsdesk - Feb 22, 2024, 5:03PM
- Recap: Collegium Pharmaceutical Q4 EarningsBenzinga Insights - Feb 22, 2024, 4:35PM
- Collegium Pharmaceutical Q4 2023 Adj EPS $1.58 Beats $0.66 Estimate, Sales $149.75M Beat $147.82M EstimateBenzinga Newsdesk - Feb 22, 2024, 4:32PM
- Earnings Scheduled For February 22, 2024Benzinga Insights - Feb 22, 2024, 5:27AM
Friday, February 02, 2024
Thursday, January 04, 2024
- Needham Maintains Buy on Collegium Pharmaceutical, Raises Price Target to $40Benzinga Newsdesk - Jan 4, 2024, 12:54PM
- Truist Securities Maintains Buy on Collegium Pharmaceutical, Raises Price Target to $37Benzinga Newsdesk - Jan 4, 2024, 11:26AM
- Jefferies Downgrades Collegium Pharmaceutical to Hold, Raises Price Target to $37Benzinga Newsdesk - Jan 4, 2024, 8:09AM
Wednesday, January 03, 2024
- Collegium Pharmaceutical shares are trading higher after the company provided 2024 financial guidance and announced its board of directors authorized a $150 million share repurchase program.Benzinga Newsdesk - Jan 3, 2024, 1:08PM
- Why Collegium Pharmaceutical Shares Are Gaining TodayAkanksha Bakshi - Jan 3, 2024, 11:39AM
- TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On WednesdayAvi Kapoor - Jan 3, 2024, 10:24AM
- Collegium Board Approves Up To $150M Share Repurchase ProgramBenzinga Newsdesk - Jan 3, 2024, 8:04AM
- Collegium Sees 2024 Net Product Revenues In Range Of $580M-$595M, Adj. eBITDA In Range Of $380M-$395MBenzinga Newsdesk - Jan 3, 2024, 8:04AM
Monday, November 27, 2023
Thursday, November 09, 2023
Wednesday, November 08, 2023
Tuesday, November 07, 2023
- Collegium Revises 2023 Product Revenues, Net Outlook From $565M-$580M To $565M-$570MBenzinga Newsdesk - Nov 7, 2023, 5:46PM
- Collegium Pharmaceutical Q3 Adj EPS $1.34 Vs $1.10 Prior Year, Sales $136.71M Miss $138.53M EstimateBenzinga Newsdesk - Nov 7, 2023, 4:44PM
- Recap: Collegium Pharmaceutical Q3 EarningsBenzinga Insights - Nov 7, 2023, 4:15PM
- Earnings Scheduled For November 7, 2023Benzinga Insights - Nov 7, 2023, 6:34AM
Friday, August 25, 2023
Thursday, August 24, 2023
Monday, August 07, 2023
Friday, August 04, 2023
- HC Wainwright & Co. Reiterates Neutral on Collegium PharmaceuticalBenzinga Newsdesk - Aug 4, 2023, 12:49PM
- Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On FridayLisa Levin - Aug 4, 2023, 10:32AM
- Needham Reiterates Buy on Collegium Pharmaceutical, Maintains $35 Price TargetBenzinga Newsdesk - Aug 4, 2023, 6:27AM
Thursday, August 03, 2023
Tuesday, May 30, 2023
Friday, May 05, 2023
Thursday, May 04, 2023
- Recap: Collegium Pharmaceutical Q1 EarningsBenzinga Insights - May 4, 2023, 4:11PM
- Collegium Pharmaceutical Q1 Adj EPS $1.32 Beats $0.31 Estimate, Sales $144.77M Beat $138.47M EstimateBenzinga Newsdesk - May 4, 2023, 4:08PM
- Collegium Pharmaceutical Q1 EPS $1.32 Beats $0.31 Estimate, Sales $144.77M Beat $138.47M EstimateBenzinga Newsdesk - May 4, 2023, 4:07PM
- Earnings Scheduled For May 4, 2023Benzinga Insights - May 4, 2023, 6:34AM